Chemistry:Pinatuzumab vedotin
From HandWiki
Short description: Monoclonal antibody
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | CD22 |
Clinical data | |
Other names | DCDT2980S, FCU2703 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6748H10377N1773O2083S44 |
Molar mass | 151081.21 g·mol−1 |
Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]
This drug was developed by Genentech/Roche.[citation needed]
References
- ↑ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108". WHO Drug Information 26 (4). https://www.who.int/medicines/publications/druginformation/innlists/PL108.pdf.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin, American Medical Association.
![]() | Original source: https://en.wikipedia.org/wiki/Pinatuzumab vedotin.
Read more |